A punchy Headline

Choose a vibrant image and write an inspiring paragraph about it.
It does not have to be long, but it should reinforce your image.

A punchy Headline

Choose a vibrant image and write an inspiring paragraph about it.
It does not have to be long, but it should reinforce your image.

Add a caption to enhance the meaning of this image.

Biological pathways 

Harnessing Biological Systems

Novacta Biosystems is a biotechnology company with a proprietary technology platform that harnesses the specificity and efficiency of biological systems, including biosynthetic pathway engineering, biotransformations and metabolite factories, in drug discovery and commercial applications in the chemicals industry.

Novacta Biosystems delivers innovative products and services into the healthcare, food, cosmetic and chemical industries. Through the utilisation of leading edge technology and many years of experience in the pharmaceutical and biotechnology industry, Novacta has been able to meet the commercial requirements of several clients and partners while continuing to develop internal products.

Access to Novacta’s skills and insights is possible through collaborations and/or licence arrangements

Contact us

3,000 students graduate each year find a job within 2 months

Join them and increase your chances to get hired.

Driven by Excellence

Teachers are selected among experts of 
Lantibiotics in full Screen Novacta’s pharmaceutical research and development focuses on biologically active compounds produced by microorganisms, also known as ‘natural products’. Novacta has identified an exciting class of compounds, known as lantibiotics, as a target for development. The lantibiotics are highly modified peptides, combining the beneficial biological interactions and versatility of peptides with desirable pharmaceutical properties such as stability in the systemic circulation. These compounds have good potential as therapeutic agents, possessing a broad range of biological activities.
Fighting Drug resistance

Lantibiotics have shown promising activity against bacteria resistant to commonly used antibacterials, including methicillin resistant Staphylococcus aureus (MRSA). These compounds have not previously progressed to clinical trials, however, because their complex structure has made it difficult to optimise their activity through conventional routes. Novacta’s innovative technology platform is designed to address this issue, enabling the structure of these complex molecules to be customised to order during their biosynthesis.
New Therapeutic Areas

As a result of the wide variety of structures that can be generated by Novacta’s technology platform, we are currrently in the process of developing several novel drug candidates within therapeutic areas including anti-virals, oncology and respiratory diseases.working effectively in their fields of excellence.

Learn more


What makes us different?

We make sure that everyone blossoms. We keep a human size in a warm and modern setting. All students benefit from individualised support.

All students benefit from individualised support.

Discover more


Are you searching for a school where cutting-edge programmes are taught, in a continually evolving environment and located in the heart of a dynamic city? You have just found it!

More Details

The campus

The small and modern campus is only a 10-minute walk away from the city centre and is easily accessible by car and public transport. It is also close to the train stations.

More Details